|
US4911920A
(en)
|
1986-07-30 |
1990-03-27 |
Alcon Laboratories, Inc. |
Sustained release, comfort formulation for glaucoma therapy
|
|
FR2588189B1
(fr)
|
1985-10-03 |
1988-12-02 |
Merck Sharp & Dohme |
Composition pharmaceutique de type a transition de phase liquide-gel
|
|
ATE141502T1
(de)
|
1991-01-15 |
1996-09-15 |
Alcon Lab Inc |
Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen
|
|
US5212162A
(en)
|
1991-03-27 |
1993-05-18 |
Alcon Laboratories, Inc. |
Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
|
|
DE19859684A1
(de)
*
|
1998-12-23 |
2000-06-29 |
Bayer Ag |
Verfahren zur Herstellung von Fluor enthaltenden Phenethylaminen sowie neue, Fluor enthalende beta-Iminovinyl- und beta-Iminoethylbenzole
|
|
JP2002293764A
(ja)
*
|
2001-01-26 |
2002-10-09 |
Takeda Chem Ind Ltd |
アミノエタノール誘導体
|
|
US7267121B2
(en)
|
2004-04-20 |
2007-09-11 |
Aerogen, Inc. |
Aerosol delivery apparatus and method for pressure-assisted breathing systems
|
|
HN2005000795A
(es)
*
|
2004-10-15 |
2010-08-19 |
Aventis Pharma Inc |
Pirimidinas como antagonistas del receptor de prostaglandina d2
|
|
WO2006079999A2
(en)
|
2006-04-09 |
2006-08-03 |
Barth Frederik H |
Induction of a novel state of mind with a 5-ht2a agonist and a nmda antagonist
|
|
WO2008016677A2
(en)
|
2006-08-02 |
2008-02-07 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of deuterated amphetamines
|
|
CN104906669A
(zh)
|
2007-03-30 |
2015-09-16 |
菲利普莫里斯生产公司 |
用于输送药剂的装置和方法
|
|
WO2016040822A1
(en)
*
|
2014-09-12 |
2016-03-17 |
Pinpoint Testing, Llc |
Ready-to-constitute analytical platforms for chemical analyses and quantification
|
|
PL3625228T3
(pl)
*
|
2017-05-18 |
2021-12-20 |
Idorsia Pharmaceuticals Ltd |
Pochodne pirymidyny jako modulatory receptora pge2
|
|
EP4353314A3
(en)
|
2019-02-22 |
2024-07-03 |
GH Research Ireland Limited |
5-methoxy-n,n-dimethyltryptamine (5-meo-dmt) for treating major depression
|
|
EP4219498A1
(en)
|
2019-03-07 |
2023-08-02 |
Arbormentis LLC |
Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic / psychotomimetic dosages and formulations
|
|
KR20220009954A
(ko)
|
2019-04-17 |
2022-01-25 |
컴퍼스 패쓰파인더 리미티드 |
신경인지 장애, 만성 통증을 치료하고 염증을 감소시키는 방법
|
|
GB201907871D0
(en)
|
2019-06-03 |
2019-07-17 |
Small Pharma Ltd |
Therapeutic compositions
|
|
WO2021003467A1
(en)
|
2019-07-04 |
2021-01-07 |
Sw Holdings, Inc. |
Metered dosing compositions and methods of use of psychedelic compounds
|
|
CN112430187B
(zh)
|
2019-08-07 |
2023-01-17 |
北京奇点势能科技有限公司 |
一种α,β-氘代胺类化合物、氘代药物及其制备方法
|
|
US11246860B2
(en)
|
2019-11-07 |
2022-02-15 |
Lophora ApS |
5-HT2A agonists for use in treatment of depression
|
|
WO2021234608A1
(en)
|
2020-05-19 |
2021-11-25 |
Cybin Irl Limited |
Deuterated tryptamine derivatives and methods of use
|
|
EP3902541B1
(en)
|
2020-06-02 |
2022-09-14 |
Small Pharma Ltd |
Therapeutic compositions comprising deuterated or partially deuterated n,n-dimethyltryptamine compounds
|
|
RU199823U1
(ru)
|
2020-06-10 |
2020-09-21 |
Общество С Ограниченной Ответственностью "Центр Передовых Радиационных Медицинских И Биологических Технологий |
Устройство для лечения бронхолегочных заболеваний
|
|
US12122741B2
(en)
|
2020-08-18 |
2024-10-22 |
Cybin Irl Limited |
Therapeutic phenethylamine compositions and methods of use
|
|
JP2023544724A
(ja)
|
2020-10-02 |
2023-10-25 |
サイビン アイアールエル リミテッド |
吸入による幻覚発動薬の送達方法および方法を実施するためのシステム
|
|
WO2022182602A2
(en)
|
2021-02-24 |
2022-09-01 |
Mind Medicine, Inc. |
Mescaline derivatives with modified action
|
|
US20220323378A1
(en)
|
2021-04-03 |
2022-10-13 |
Shawn Joseph |
Pharmaceutical Compositions and Methods for Treating Mental Health Disorders and Promoting Neural Plasticity
|
|
WO2022221942A1
(en)
|
2021-04-19 |
2022-10-27 |
Betterlife Pharma Inc. |
Prevention of drug diversion
|
|
WO2022225884A1
(en)
|
2021-04-22 |
2022-10-27 |
Lennham Pharmaceuticals, Inc. |
Deuterated derivatives of psychedelic compounds and uses thereof
|
|
BR112023025599A2
(pt)
|
2021-06-08 |
2024-02-20 |
Entheogenix Biosciences Inc |
Ativadores de dimetoxifenilalquilamina de receptores de serotonina.
|
|
WO2022271982A1
(en)
|
2021-06-23 |
2022-12-29 |
Synaptive Therapeutics, Llc |
Substituted phenethylamine for treating inflammation and psychological disorders
|
|
WO2023283386A2
(en)
|
2021-07-07 |
2023-01-12 |
Arcadia Medicine, Inc. |
Safer psychoactive compositions
|
|
CA3209813A1
(en)
|
2021-07-14 |
2023-01-19 |
Mydecine Innovations Group Inc. |
Novel short-acting psychoactive compounds of the mdma class
|
|
CA3229713A1
(en)
|
2021-08-20 |
2023-02-23 |
Terran Biosciences Inc. |
Deuterated analogs and derivatives of 4-bromo-2,5-dimethoxyphenethylamine and uses thereof
|
|
WO2023036473A1
(en)
|
2021-09-08 |
2023-03-16 |
Cybin Irl Limited |
Combination drug therapies
|
|
EP4405318A4
(en)
|
2021-09-25 |
2025-11-05 |
Alexander Shulgin Res Institute Inc |
PHENYLAKYLAMINES SUBSTITUTED
|
|
CA3244130A1
(en)
|
2022-02-15 |
2023-08-24 |
Cybin Irl Limited |
PHENETYLAMINE DERIVATIVES, COMPOSITIONS AND METHODS OF USE
|
|
KR20240153566A
(ko)
|
2022-02-15 |
2024-10-23 |
사이빈 아이알엘 리미티드 |
치료적 펜에틸아민 조성물, 및 사용 방법
|
|
AU2023242469A1
(en)
|
2022-03-31 |
2024-09-05 |
Cybin Irl Limited |
Combination of nitrous oxide and 5-ht2a receptor agonists
|
|
AU2023246690A1
(en)
|
2022-03-31 |
2024-11-07 |
Cybin Irl Limited |
Methods for delivery of psychedelic medications by inhalation and systems for performing the methods
|
|
KR20250097837A
(ko)
|
2022-10-28 |
2025-06-30 |
사이빈 아이알엘 리미티드 |
펜에틸아민 화합물, 조성물, 및 사용 방법
|